U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Semaglutide (WEGOVY®) Injection
Status: Currently in Shortage
»Date first posted: 03/31/2022
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Novo Nordisk, Inc. (Revised 09/14/2022)

Company Contact Information:
833-493-4689

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.25 mg / 0.5mL (NDC 0169-4525-14) Distribution of this dose temporarily paused, resumption of supply expected towards the end of 2022. Requirements related to complying with good manufacturing practices.
0.5 mg / 0.5mL (NDC 0169-4505-14) Distribution of this dose temporarily paused, resumption of supply expected towards the end of 2022. Requirements related to complying with good manufacturing practices.
1 mg / 0.5mL (NDC 0169-4501-14) Currently unavailable; Resumption of supply expected towards the end of 2022. Requirements related to complying with good manufacturing practices.
1.7 mg / 0.75mL (NDC 0169-4517-14) Currently available Requirements related to complying with good manufacturing practices.
2.4 mg / 0.75mL (NDC 0169-4524-14) Currently available Requirements related to complying with good manufacturing practices.
Back to Top